Syncona Limited

Syncona Limited

SYNC · LSE · Financial Services / Asset Management

126.20GBX-0.60 (-0.47%)

Price History

Full chart

Market Stats

Previous Close126.80
Open126.80
Day Range126.20 – 128.00
52-Week Range86.80 – 124.40
Volume168.23K
Market Cap742.01M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.29
50-Day Avg112.35
200-Day Avg100.76

About

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEODr. Christopher J. Hollowood Ph.D.
  • Employees1.23K
  • HeadquartersVictoria House, London, United Kingdom, WC1B 4DA, UK
  • Websitehttps://www.synconaltd.com

Leadership

  • Mr. Kenneth H. Galbraith C.A.Chair of SIML & Executive Partner · b. 1962
  • Dr. Christopher J. Hollowood Ph.D.Chief Executive Officer · b. 1974
  • Ms. Katherine Elizabeth ButlerChief Financial officer · b. 1981
  • Ms. Fiona FernandezHead of Operations
  • Dr. Elisa Petris Ph.D.Managing Partner
  • Ms. Annabel ClarkHead of Corporate Affairs
  • Mr. Roel BulthuisManaging Partner and Head of Investments · b. 1976
  • Dr. Samantha Roberts M.D., Ph.D.Executive Partner
  • Ms. Raghd RostomPrincipal

Financials

Income Statement

Currency: GBP2013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue66.17M13.48M55.30M4.75M83.16M196.44M439.12M-167.31M78.54M18.69M-39.79M30.75M-68.31M57.34M
Growth (%)--79.63%+310.27%-91.41%+1650.78%+136.21%+123.54%-138.10%+146.94%-76.20%-312.87%+177.28%-322.16%+183.93%
Cost of Revenue--002.82M7.60M25.87M7.52M12.12M15.01M12.12M16.64M-13.97M
Gross Profit66.17M13.48M55.30M4.75M80.34M188.84M413.25M-174.82M78.54M3.68M-51.91M14.10M-68.31M43.36M
Gross Margin100.00%100.00%100.00%100.00%96.61%96.13%94.11%104.49%100.00%19.70%130.46%45.87%100.00%75.63%
Operating Expense753.60K753.00K903.00K998.00K-1.70M7.45M-2.31M16.13M20.67M-9.41M-528.00K5.96M74.85M50.19M
Operating Income65.42M12.73M54.40M3.75M82.04M181.38M415.56M-190.95M57.87M13.09M-51.38M8.14M-143.16M-6.83M
Operating Margin98.86%94.41%98.37%78.99%98.65%92.33%94.64%114.13%73.68%70.02%129.13%26.48%209.57%-11.91%
EBITDA-4.10M12.73M54.40M3.75M82.04M181.38M428.91M-1.91M57.87M11.15M-4.63M8.14M-143.16M-8.80M
EBITDA Margin-6.20%94.41%98.37%78.99%98.65%92.33%97.68%1.14%73.68%59.64%11.65%26.48%209.57%-15.36%
Net Income61.32M9.54M49.68M-1.00M77.29M172.83M411.26M-195.56M53.16M8.84M-56.02M3.79M-143.16M-8.80M
Net Income Margin92.66%70.76%89.83%-21.05%92.94%87.98%93.66%116.89%67.68%47.28%140.78%12.32%209.57%-15.36%
Interest Expense-000000000----
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%----

Balance Sheet

Currency: GBP2013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets230.73M438.33M483.61M477.13M901.35M1.07B1.48B1.28B1.34B1.33B1.27B1.25B1.06B1.05B
Total Liabilities1.13M3.48M4.55M4.88M6.11M15.18M23.89M30.31M38.12M23.55M13.76M12.22M11.79M14.95M
Total Equity229.61M434.85M479.06M472.25M895.24M1.06B1.46B1.25B1.30B1.31B1.25B1.24B1.05B1.04B
Cash299.00K44.66M23.00K41.00K105.00K981.00K91.00K17.00K14.00K276.00K11.00K261.00K1.11M1.92M
Net Debt-299.00K-44.66M-23.00K-41.00K-105.00K-981.00K-91.00K-17.00K-14.00K-276.00K-11.00K-261.00K-1.11M-1.92M

Cash Flow

Currency: GBP2013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow-633.60K4.43M5.41M5.84M7.12M8.19M300.00K13.17M-3.00K262.00K-265.00K20.47M43.91M23.33M
Investing Cash Flow-406.05M-190.98M-165.24M-165.24M-165.24M5.14M10.97M-------15.75M
Financing Cash Flow489.77M195.69M-5.46M-5.82M158.18M-12.45M-12.16M-13.25M-13.25M---20.22M-43.06M-6.78M
Capital Expenditure00000000000043.91M23.33M
Free Cash Flow-633.60K4.43M5.41M5.84M7.12M8.19M300.00K13.17M-3.00K262.00K-265.00K20.47M43.91M23.33M
Dividends Paid-2.07M5.46M5.82M6.66M12.45M12.16M13.25M13.25M-----
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF-46.66%100.98%99.69%93.62%152.01%4052.33%100.56%-441533.33%-----

Earnings

Report DateNov 12, 2026
EPS Estimate-
EPS Actual-
Surprise-
TimingPre-market

Key Statistics & Ratios

Market Cap742.01M
Enterprise Value740.08M
Trailing P/E0.00
Forward P/E0.00
Price / Sales36.60
Price / Book0.69
EPS-0.01
Book Value4.47
Revenue (TTM)20.27M
Gross Profit (TTM)20.27M
Profit Margin-43.43%
Operating Margin61.00%
Return on Equity-0.84%
Return on Assets-0.31%
Shares Outstanding608.20M
Shares Float476.93M
Beta0.29
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20191×
0.02Jun 20, 2019
20181×
0.02Jun 21, 2018
20171×
0.02Jul 20, 2017
20161×
0.02Jul 14, 2016
20151×
0.02Jul 16, 2015
20141×
0.02Aug 6, 2014
20131×
0.01Jul 18, 2013